drugset / Trial / NCT00649870

Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mg

NCT00649870

Phase 1 Completed 26 enrolled Mylan Pharmaceuticals Inc
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study was to investigate the bioequivalence of Mylan's valacyclovir hydrochloride 1000 mg tablets to GlaxoSmithKline's Valtrex® 1000 mg tablets following a single, oral 1000 mg (1 x 1000 mg) dose administration under fed conditions.

Timeline

Start
2005-05
Primary completion
2005-05
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Valacyclovir Unknown 1000 mg Oral

Indications

No indication recorded.